Here are three stocks with buy rank and strong value characteristics for investors to consider today, December 24:

Puma Biotechnology, Inc. (PBYI Quick QuotePBYI - Free Report) : This biopharmaceutical company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 14% over the last 60 days.

Puma Biotechnology, Inc. Price and Consensus

Puma Biotechnology, Inc. price-consensus-chart | Puma Biotechnology, Inc. Quote

Puma Biotechnology has a price-to-earnings ratio (P/E) of 5.57 compared with 24.71 for the S&P. The company possesses a Value Scoreof A.

Puma Biotechnology, Inc. PE Ratio (TTM)

Puma Biotechnology, Inc. pe-ratio-ttm | Puma Biotechnology, Inc. Quote

Dillard's, Inc. (DDS Quick QuoteDDS - Free Report) : This retail company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.6% over the last 60 days.

Dillard's, Inc. Price and Consensus

Dillard's, Inc. price-consensus-chart | Dillard's, Inc. Quote

Dillard's has a price-to-earnings ratio (P/E) of 13.06 compared with 24.71 for the S&P. The company possesses a Value Score of A.

Dillard's, Inc. PE Ratio (TTM)

Dillard's, Inc. pe-ratio-ttm | Dillard's, Inc. Quote

Premier, Inc. : This healthcare improvement company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.7% over the last 60 days.

Premier, Inc. Price and Consensus

Premier, Inc. price-consensus-chart | Premier, Inc. Quote

Premier has a price-to-earnings ratio (P/E) of 16.87 compared with 24.71 for the S&P. The company possesses a Value Score of A.

Premier, Inc. PE Ratio (TTM)

Premier, Inc. pe-ratio-ttm | Premier, Inc. Quote

See the full list of top ranked stocks here.

Learn more about the Value score and how it is calculated here.